Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-151232
Filing Date
2025-06-27
Accepted
2025-06-27 16:01:14
Documents
20
Period of Report
2025-06-27

Document Format Files

Seq Description Document Type Size
1 6-K d42309d6k.htm 6-K 12282
2 EX-1.1 d42309dex11.htm EX-1.1 1220549
3 GRAPHIC g42309dsp174.jpg GRAPHIC 2904
4 GRAPHIC g42309dsp175.jpg GRAPHIC 3241
5 GRAPHIC g42309dsp177.jpg GRAPHIC 3267
6 GRAPHIC g42309dsp178.jpg GRAPHIC 3330
7 GRAPHIC g42309dsp179.jpg GRAPHIC 2891
8 GRAPHIC g42309dsp180.jpg GRAPHIC 4713
9 GRAPHIC g42309dsp_24a.jpg GRAPHIC 4088
10 GRAPHIC g42309dsp_25a.jpg GRAPHIC 8516
11 GRAPHIC g42309dsp_25b.jpg GRAPHIC 3517
12 GRAPHIC g42309dsp_26a.jpg GRAPHIC 6627
13 GRAPHIC g42309dsp_33a.jpg GRAPHIC 4038
14 GRAPHIC g42309dsp_33b.jpg GRAPHIC 8461
15 GRAPHIC g42309dsp_34a.jpg GRAPHIC 3435
16 GRAPHIC g42309dsp_34b.jpg GRAPHIC 6195
17 GRAPHIC g42309page43.jpg GRAPHIC 4095
18 GRAPHIC g42309page44a.jpg GRAPHIC 8242
19 GRAPHIC g42309page44b.jpg GRAPHIC 3273
20 GRAPHIC g42309page45.jpg GRAPHIC 6491
  Complete submission text file 0001193125-25-151232.txt   1356752
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 251086152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)